A detailed history of Kbc Group Nv transactions in Twist Bioscience Corp stock. As of the latest transaction made, Kbc Group Nv holds 1,716 shares of TWST stock, worth $70,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,716
Previous 1,716 -0.0%
Holding current value
$70,544
Previous $85,000 8.24%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$32.28 - $41.5 $18,399 - $23,655
570 Added 49.74%
1,716 $59,000
Q4 2023

Feb 13, 2024

BUY
$15.08 - $38.61 $17,281 - $44,247
1,146 New
1,146 $42,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.32B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.